首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Rapidly Boosted Plasma IL-5 Induced by Treatment of Human Schistosomiasis haematobium Is Dependent on Antigen Dose IgE and Eosinophils
【2h】

Rapidly Boosted Plasma IL-5 Induced by Treatment of Human Schistosomiasis haematobium Is Dependent on Antigen Dose IgE and Eosinophils

机译:通过治疗人类血吸虫性血友病诱导的血浆IL-5快速升高取决于抗原剂量IgE和嗜酸性粒细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIgE specific to worm antigen (SWA) and pre-treatment eosinophil number, are associated with human immunity to re-infection with schistosomes after chemotherapeutic treatment. Treatment significantly elevates circulating IL-5 24-hr post-treatment of Schistosoma mansoni. Here we investigate if praziquantel treatment of human schistosomiasis haematobium also boosts circulating IL-5, the immunological and parasitological factors that predispose to this, and the relationship between these and subsequent immunity to post-treatment re-infection.
机译:特异于蠕虫抗原(SWA)和治疗前嗜酸性粒细胞数量的BackgroundIgE与人类对化疗治疗后血吸虫重新感染的免疫力有关。治疗显着提高曼氏血吸虫治疗后24小时的循环IL-5水平。在这里,我们研究了吡喹酮治疗人血吸虫病的血友病是否也会促进循环中的IL-5,免疫和寄生虫病诱因,以及它们与随后对治疗后再感染的免疫力之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号